- Home
- AUPH vs ARR Comparison
AUPH vs ARR Comparison
Compare AUPH & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | ARR |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUPH | ARR |
|---|---|---|
| Price | $14.93 | $16.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $17.25 | ★ $18.50 |
| AVG Volume (30 Days) | 1.2M | ★ 4.3M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 16.69% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | N/A |
| Revenue Next Year | $15.74 | N/A |
| P/E Ratio | $60.02 | ★ $27.18 |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $10.34 | $13.98 |
| 52 Week High | $19.25 | $19.31 |
Technical Indicators
Market Signals| Indicator | AUPH | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 40.04 |
| Support Level | $14.60 | $16.10 |
| Resistance Level | $15.23 | $17.57 |
| Average True Range (ATR) | 0.49 | 0.35 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 17.08 | 23.91 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.